Cardiff Oncology, Inc. — All Filings
1,005 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-12G
10-12G/A
10-K
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
10QSB/A
25-NSE
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFR14A
EFFECT
FWP
NT 10-K
NT 10-Q
NTN 10K
POS AM
PRE 14A
PRER14A
REGDEX
REGDEX/A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3ASR
S-8
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0000950170-24-134749 | Dec 10, 2024 | — |
| SC 13G | — | 0002012383-24-003492 | Nov 8, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-123242 | Nov 7, 2024 | Sep 30, 2024 |
| 8-K | 8-K | 0000950170-24-123303 | Nov 7, 2024 | — |
| SC 13G | — | 0002012383-24-002184 | Oct 24, 2024 | — |
| 10-Q | 10-Q | 0001628280-24-036098 | Aug 8, 2024 | Jun 30, 2024 |
| 8-K | 8-K | 0001628280-24-036122 | Aug 8, 2024 | — |
| 4 | FORM 4 | 0001628280-24-030642 | Jul 1, 2024 | Jun 27, 2024 |
| S-8 | S-8 | 0001628280-24-030627 | Jul 1, 2024 | — |
| 4 | FORM 4 | 0001628280-24-030643 | Jul 1, 2024 | Jun 27, 2024 |
| 4 | FORM 4 | 0001628280-24-030638 | Jul 1, 2024 | Jun 27, 2024 |
| 4 | FORM 4 | 0001628280-24-030636 | Jul 1, 2024 | Jun 27, 2024 |
| 4 | FORM 4 | 0001628280-24-030640 | Jul 1, 2024 | Jun 27, 2024 |
| 4 | FORM 4 | 0001628280-24-030641 | Jul 1, 2024 | Jun 27, 2024 |
| 8-K | 8-K | 0001628280-24-029108 | Jun 20, 2024 | — |
| DEFA14A | DEFA14A | 0001104659-24-071955 | Jun 17, 2024 | — |
| DEFA14A | DEFA14A | 0001628280-24-026307 | Jun 3, 2024 | — |
| 8-K | 8-K | 0001628280-24-026295 | Jun 3, 2024 | May 30, 2024 |
| 10-Q | 10-Q | 0001628280-24-019974 | May 2, 2024 | Mar 31, 2024 |
| 8-K | 8-K | 0001628280-24-020010 | May 2, 2024 | — |
| DEFA14A | DEFA14A | 0001628280-24-018171 | Apr 25, 2024 | — |
| DEF 14A | DEF 14A | 0001628280-24-018143 | Apr 25, 2024 | Jun 20, 2024 |
| ARS | ARS | 0001628280-24-018164 | Apr 25, 2024 | Dec 31, 2023 |
| 8-K | 8-K | 0001628280-24-015247 | Apr 8, 2024 | — |
| S-8 | S-8 | 0001628280-24-013289 | Mar 27, 2024 | — |
| 4 | FORM 4 | 0001628280-24-009746 | Mar 7, 2024 | — |
| 4 | FORM 4 | 0001628280-24-009747 | Mar 7, 2024 | — |
| 4 | FORM 4 | 0001628280-24-009745 | Mar 7, 2024 | — |
| 4 | FORM 4 | 0001628280-24-009748 | Mar 7, 2024 | — |
| 10-K | 10-K | 0001628280-24-007948 | Feb 29, 2024 | Dec 31, 2023 |
| 8-K | 8-K | 0001628280-24-007972 | Feb 29, 2024 | — |
| SC 13G/A | CARDIFF ONCOLOGY, INC. | 0000902664-24-001100 | Feb 6, 2024 | — |
| 8-K | 8-K | 0001628280-24-000780 | Jan 8, 2024 | — |
| 4 | FORM 4 | 0001628280-23-042045 | Dec 19, 2023 | — |
| 4 | FORM 4 | 0001628280-23-038955 | Nov 14, 2023 | Nov 10, 2023 |
| 10-Q | 10-Q | 0001628280-23-036375 | Nov 2, 2023 | Sep 30, 2023 |
| 8-K | 8-K | 0001628280-23-036386 | Nov 2, 2023 | — |
| 8-K | 8-K | 0001628280-23-033014 | Sep 26, 2023 | — |
| 10-Q | 10-Q | 0001628280-23-028549 | Aug 9, 2023 | Jun 30, 2023 |
| 8-K | 8-K | 0001628280-23-028563 | Aug 9, 2023 | Aug 8, 2023 |
| 8-K | FORM 8-K | 0001104659-23-088391 | Aug 7, 2023 | — |
| 8-K | 8-K | 0001628280-23-025483 | Jul 24, 2023 | — |
| 4 | FORM 4 | 0001628280-23-022731 | Jun 20, 2023 | Jun 15, 2023 |
| 4 | FORM 4 | 0001628280-23-022732 | Jun 20, 2023 | Jun 15, 2023 |
| 4 | FORM 4 | 0001628280-23-022734 | Jun 20, 2023 | Jun 15, 2023 |
| 4 | FORM 4 | 0001628280-23-022736 | Jun 20, 2023 | Jun 15, 2023 |
| 4 | FORM 4 | 0001628280-23-022738 | Jun 20, 2023 | Jun 15, 2023 |
| 4 | FORM 4 | 0001628280-23-022742 | Jun 20, 2023 | Jun 15, 2023 |
| 8-K | 8-K | 0001628280-23-022757 | Jun 20, 2023 | — |
| 8-K | 8-K | 0001628280-23-022271 | Jun 15, 2023 | — |